Gulf war depleted uranium risks

Journal of Exposure Science and Environmental Epidemiology

Volumn 18, Issue 1, 2008, Pages 95-108

  Marshall, Albert C ^a  

^a SANDIA NATIONAL LABORATORIES   (United States)

Author keywords

Analytical methods; Cancer; Exposure modeling; Inhalation exposure; Metals; Particulate matter; Radiation

Indexed keywords

URANIUM;

ARMY; ARTICLE; BIRTH DEFECT; COMPARATIVE STUDY; CONTAMINATION; ENVIRONMENT; EXPOSURE; HEALTH HAZARD; HUMAN; IMMUNOPATHOLOGY; KIDNEY INJURY; LEUKEMIA; MATHEMATICAL MODEL; NEOPLASM; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; VETERAN; WAR;

ANIMALS; CONGENITAL ABNORMALITIES; ENVIRONMENTAL EXPOSURE; GULF WAR; HUMANS; IMMUNE SYSTEM; LEUKEMIA; MILITARY PERSONNEL; PERSIAN GULF SYNDROME; PUBLIC HEALTH; RADIOACTIVE POLLUTANTS; RISK ASSESSMENT; TIME FACTORS; URANIUM;

ANIMALIA;

EID: 37349082409     PISSN: 15590631     EISSN: 1559064X     Source Type: Journal    
DOI: 10.1038/sj.jes.7500551     Document Type: Article

References (41)

1. Araneta M.R.G., Scglangen K.M., Edmonds L.D., Destiche D.A., Merz R.D., Hobbs C.A., et al. Prevalence of birth defects among infants of gulf war veterans in Arkansas, Arizona, California, Georgia, Hawaii, and Iowa. Birth Defects Res A Clin Mol Teratol 2003: 67: 246-260.
2. Arfsten D.P., Still K.R., and Ritchie G.D. A review of uranium and depleted uranium exposure on reproduction and fetal development. Toxicol Ind Health 2001: 17: 180-191.
3. Bem H., and Bou-Rabi F. Environmental consequences of depleted uranium use in the 1991 Gulf War. Enviro Int 2003: 30: 123-134.
4. Bleise A., Danesi P.R., and Burkart W. Properties, use and health effects of depleted uranium (DU): a general overview. J Environ Radioact 2003: 64: 93-112.
5. Catalinotto J., and Flounders S., In: (Eds). Metal of Dishonor-Depleted Uranium: How the Pentagon Radiates Soldiers & Civilians with DU Weapons, International Action Center: New York NY, 2004.
6. Cowan D.N., DeFraites R.F., Gray G.C., Goldenbaum M.B., and Wishik S.M. The risk of birth defects among children of Persian Gulf War veterans. N Engl J Med 1997: 336: 1650-1656.
7. Domingo J.L. Chemical toxicity of uranium. Toxicol Ecotoxicol News 1995: 2: 74-78.
8. Domingo J.L. Reproductive and developmental toxicity of natural and depleted uranium: a review. Reprod Toxicol 2001: 15: 603-609.
9. Domingo J.L., Paternain J.L., Llobet J.M., and Corbella J. The developmental toxicity of uranium in mice. Toxicology 1989: 55: 143-152.
10. Fetter S., and von Hippel F.N. The hazard posed by depleted uranium munitions. Sci Global Security 1999: 8: 125-161.
11. Guilmette R.A., Parkhurst M.A., Miller G., Hahn F.F., Roszell L.E., Daxon E.G., et al. Human health risk assessment of capstone depleted uranium aerosols. Battelle Pacific Northwest Laboratory report PNWD-3442, October 2004.
12. Hahn F.F., Guilmette R.A., and Hoover M.D. Implanted depleted uranium fragments cause soft tissue sarcomas in the muscles of rats. Environ Health Perspect 2002: 110: 51-59.
13. ICRP. ICRP publication 30: Limits of intakes of radionuclides by workers. Pergamon: New York, NY, 1979.
14. ICRP. ICRP publication 60: 1990 recommendations of the International Commission on Radiological Protection. Pergamon: New York, NY, 1991.
15. ICRP. ICRP publication 66: Human respiratory tract model for radiological protection. Pergamon: New York, NY, 1994.
16. ICRP. ICRP publication 69: Age-dependent doses to members of the public from intake of radionuclides: part 3 ingestion dose coefficients. Pergamon: New York, NY, 1995.
17. Italian Ministry of Defense. Preliminary report - Investigative Commission of the Italian Ministry of Defense on the incidence of malignant neoplasia among military personnel involved in operations in Bosnia and Kosovo, March 2001.
18. Leggett R.W., and Pellmar T.C. The biokinetics of uranium migrating from embedded DU fragments. J Environ Rad 2003: 64: 205-225.
19. Marshall A.C. An analysis Of uranium dispersal and health effects using a gulf war case study, Sandia National Laboratories Report SAND2005-4331, July 2005.
20. Martin F., Earl R., and Tawn E.J. A cytogenetic study of men occupationally exposed to uranium. Br J Ind Med 1991: 48: 98-102.
21. McClain D.E., Benson K.A., Dalton T.K., Ejnik J., Emond C.A., Hodge S.J., et al. Biological effects of embedded depleted uranium (DU): summary of Armed Forces Radiobiology Research Institute research. Sci Total Environ 2001: 274: 115-118.
22. McDiarmid M.A., Squibb K., Engelhardt S., Oliver M., Gucer P., Wilson P.D., et al. Surveillance of depleted uranium exposed gulf war veterans: health effects observed in an enlarged friendly fire cohort. J Occup Environ Med 2001: 43: 991-1000.
23. Mettler F.A., and Upton A.C. Medical effects of ionizing radiation, 2nd ed. WB. Saunders: Philadelphia, PA, 1995.
24. Miller A.C., Blakely W.F., Livengood D., Whittaker T., Xu J., Ejnik J.W., et al. Transformations of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride. Environ Health Perspect 1998: 106: 465-471.
25. Miller A.C., Brooks K., Smith J., and Page N. Effect of the militarily-relevant heavy metals, depleted uranium and heavy metal tungsten-alloy on gene expression in human carcinoma cells (HepG2). Mol Cell Biochem 2004: 255: 247-256.
26. Miller A.C., Xu J., Stewart M., Brooks K., Hodge S., Shi L., et al. Observation of radiation specific damage in human cells exposed to depleted uranium: dicentric frequency and neoplastic transformations as endpoints. Radiat Prot Dosimetry 2002: 99: 275-278.
27. PAC. Presidential Advisory Committee Presidential Advisory Committee on Gulf War Illnesses, Final Report Chapter 3 2005.
28. Parkhurst M.A., Szrom F., Guilmette R.A., Holmes T.D., Cheng Y.S., Kenoyer J.L., et al. Capstone depleted uranium aerosols: generation and characterization, Volumes 1 and 2. Pacific Northwest National Laboratory report PNNL-14168 October 2004.
29. Pellmar T.C., Hogan J.B., Benson K.A., and Landauer M.R. Toxicological evaluation of depleted uranium in rats: six month evaluation point. Armed Forces Radiobiology Research Institute: Bethesda MD, 1998.
30. Rostker B. Environmental exposure report: depleted uranium in the Gulf (II), Second interim DoD report. 2000179-0000002. Tab B. December. Available: http://www.gul.ink.osd.mil/du_ii/[accessed 1 June 2006] 2003.
31. Royal Society. The health hazards of depleted uranium munitions Part I. The Royal Society: London, UK, 2002a.
32. Royal Society. The health hazards of depleted uranium munitions Part II. The Royal Society: London UK, 2002b.
33. Ubios A.M., Braun E.M., and Cabrini R.L. Effect of biophosphonates on abnormal mandibular growth in rats intoxicated with uranium. Health Phys 1998: 75: 610-613.
34. Ubios A.M., Guglielmotti M.B., Steimetz T., and Cabrini R.L. Uranium inhibits bone formation in physiologic alveolar bone modeling and remodeling. Environ Res 1991: 54: 17-23.
35. United Nations Environmental Programme. Depleted uranium in bosnia and herzegovina post-conflict environmental assessment. UNEP: Nairobi, Kenya, 2003.
36. USACHPPM. Depleted uranium human exposure assessment and health risk characterization in support of the environmental exposure report "depleted uranium in the Gulf" of the Office of the Special Assistant to the Secretary Of Defense for Gulf War Illnesses, Medical Readiness and Military Deployments (OSAGWI), Health Risk Assessment (HRA) Consultation no. 26-MF-7555-00D, September 2000.
37. US Department of Energy. Guide to good practices for occupational radiological protection in uranium facilities, US DOE Standard SAFT-0072 (DRAFT), 2000.
38. U.S. Environmental Protection Agency. Nickel refinery dust data from the Integrated Risk Information System (IRIS) database, Available: http://www.epa.gov/iris/subst/0272.htm[accessed 1 June 2006] 1999.
39. + T cells, and gene expression profiles. Environ Health Perspect January 2006: 114: 85-91.
40. Waxweiler V.E., Archer, Rosco R.J., Watanabe A., and Thun M.H. Mortality patterns among a retrospective cohort of uranium mill workers. Proc 16th Midyear Topical Symposium of the Health Physics Society 1983, 428-435.
41. WHO. Depleted uranium: sources, exposure and health effects, World Health Organization Report WHO/SDE/PHE/01.1. April 2001.